SCHEMBL7216072

SCHEMBL7216072

Fc1ccc2c(C3=CCN(CCOc4cccc5c4OCCO5)CC3)c[nH]c2c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 14/20 1.00
SLC6A4 P31645 9/20 1.00
DRD2 P14416 1/20 0.51
ADRA1D P25100 1/20 0.51
HTR1D P28221 1/20 0.51
HTR1B P28222 1/20 0.51
ADRA1A P35348 1/20 0.51
ADRA1B P35368 1/20 0.51
KDM4E B2RXH2 1/20 0.49
GMNN O75496 1/20 0.49
ALDH1A1 P00352 1/20 0.49
LMNA P02545 1/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2D6 P10635 1/20 0.49
MAPT P10636 1/20 0.49
CYP2C9 P11712 1/20 0.49
ALOX15 P16050 1/20 0.49
HTR2A P28223 1/20 0.49
MAPK1 P28482 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7220964 0.93 HTR1A (1.00) HTR1ASLC6A4DRD2HTR2A
SCHEMBL7213986 0.90 HTR1A (1.00) HTR1ASLC6A4DRD2ADRA1DADRA1A
SCHEMBL7549298 0.82 HTR1A (1.00) HTR1ASLC6A4DRD2ADRA1DADRA1A
SCHEMBL6594841 0.76 HTR1A (0.68) HTR1ASLC6A4DRD2HTR2A
SCHEMBL5845217 0.76 HTR1A (0.66) HTR1ASLC6A4DRD2HTR2A
SCHEMBL6976036 0.75 HTR1A (0.63) HTR1ASLC6A4DRD2ADRA1DHTR1D
SCHEMBL7881295 0.73 HTR1A (0.81) HTR1ASLC6A4DRD2ADRA1DHTR1D
SCHEMBL7214578 0.72 HTR1A (1.00) HTR1ASLC6A4DRD2MAPK1
SCHEMBL5478675 0.72 HTR1A (1.00) HTR1A
SCHEMBL6591284 0.71 DRD2 (0.59) HTR1ASLC6A4DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6610712-B2 Treating serotonin-related central nervous system disorders WYETH 2003-08-26 US claimed
WO-2002048105-A2 ARYLOXY PIPERIDINYL DERIVATIVES FOR THE TREATMENT OF DEPRESSION WYETH (US) 2002-06-20 WO claimed
US-6610712-B2 Treating serotonin-related central nervous system disorders WYETH 2003-08-26 US disclosed
WO-2002048105-A2 ARYLOXY PIPERIDINYL DERIVATIVES FOR THE TREATMENT OF DEPRESSION WYETH (US) 2002-06-20 WO disclosed